» Articles » PMID: 22702419

New Insights into Osteoporosis: the Bone-fat Connection

Overview
Journal J Intern Med
Specialty General Medicine
Date 2012 Jun 19
PMID 22702419
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis and obesity are chronic disorders that are both increasing in prevalence. The pathophysiology of these conditions is multifactorial and includes genetic, environmental and hormonal determinants. Although it has long been considered that these are distinct disorders rarely found in the same individual, emerging evidence from basic and clinical studies support an important interaction between adipose tissue and the skeleton. It is proposed that adiposity may influence bone remodelling through three mechanisms: (i) secretion of cytokines that directly target bone, (ii) production of adipokines that influence the central nervous system thereby changing sympathetic impulses to bone and (iii) paracrine influences on adjacent skeletal cells. Here we focus on the current understanding of bone-fat interactions and the clinical implications of recent studies linking obesity to osteoporosis.

Citing Articles

ALG5 downregulation inhibits osteogenesis and promotes adipogenesis by regulating the N-glycosylation of SLC6A9 in osteoporosis.

Li Q, Liu W, Zhang Y, Jin J, Ji P, Yuan Z Cell Mol Life Sci. 2025; 82(1):35.

PMID: 39760914 PMC: 11703790. DOI: 10.1007/s00018-024-05566-9.


What Is the Best Method for Diagnosing Osteosarcopenic Adiposity in Women After Long-Term Bariatric Surgery? A Comparison and Validation of Different Criteria.

Araujo M, Lima R, Baiocchi de Carvalho K, Botelho P Nutrients. 2024; 16(22).

PMID: 39599750 PMC: 11597721. DOI: 10.3390/nu16223965.


Combined Effects of Cyclic Hypoxic and Mechanical Stimuli on Human Bone Marrow Mesenchymal Stem Cell Differentiation: A New Approach to the Treatment of Bone Loss.

Camacho-Cardenosa M, Pulido-Escribano V, Torrecillas-Baena B, Quesada-Gomez J, Herrera-Martinez A, Sola-Guirado R J Clin Med. 2024; 13(19).

PMID: 39407866 PMC: 11476683. DOI: 10.3390/jcm13195805.


The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis.

Abo-Elenin M, Kamel R, Nofal S, Ahmed A Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39254876 DOI: 10.1007/s00210-024-03378-z.


Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease.

Hu L, Chen W, Qian A, Li Y Bone Res. 2024; 12(1):39.

PMID: 38987555 PMC: 11237130. DOI: 10.1038/s41413-024-00342-8.


References
1.
Muscogiuri G, Chavez A, Gastaldelli A, Perego L, Tripathy D, Saad M . The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. Curr Vasc Pharmacol. 2008; 6(4):301-12. DOI: 10.2174/157016108785909715. View

2.
Pino A, Rodriguez J, Rios S, Astudillo P, Leiva L, Seitz G . Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin. J Endocrinol. 2006; 191(3):715-25. DOI: 10.1677/joe.1.07026. View

3.
Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H . Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 2002; 143(6):2349-56. DOI: 10.1210/endo.143.6.8854. View

4.
Fulzele K, Riddle R, DiGirolamo D, Cao X, Wan C, Chen D . Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010; 142(2):309-19. PMC: 2925155. DOI: 10.1016/j.cell.2010.06.002. View

5.
Reaven G . Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am. 2011; 95(5):875-92. DOI: 10.1016/j.mcna.2011.06.002. View